Form 4 for LPCN Lipocine Inc.
Accepted 2026-04-02 17:05:58 ET · period of report 2026-04-02 · accession 0001493152-26-014959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 17:05 | 2026-04-02 | LPCN | Patel Mahesh V. | CEO, Dir | P - Purchase | $2.02 | +25.0K | 135.7K | +23% | +$50.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2026-04-02 | P | A | 25,000 | $2.02 | 135,679 | D | — | — |